US President-elect Joe Biden may have promised a “return to normalcy,” but the truth is that there is no going back. The world is changing in fundamental ways, and the actions the world takes in the next few years will be critical to lay the groundwork for a sustainable, secure, and prosperous future.
For more than 25 years, Project Syndicate has been guided by a simple credo: All people deserve access to a broad range of views by the world’s foremost leaders and thinkers on the issues, events, and forces shaping their lives. At a time of unprecedented uncertainty, that mission is more important than ever – and we remain committed to fulfilling it.
But there is no doubt that we, like so many other media organizations nowadays, are under growing strain. If you are in a position to support us, please subscribe now.
As a subscriber, you will enjoy unlimited access to our On Point suite of long reads and book reviews, Say More contributor interviews, The Year Ahead magazine, the full PS archive, and much more. You will also directly support our mission of delivering the highest-quality commentary on the world's most pressing issues to as wide an audience as possible.
By helping us to build a truly open world of ideas, every PS subscriber makes a real difference. Thank you.
发自日内瓦—因新型冠状病毒入院的美国人中有1/5还存在细菌感染。如果缺乏有效的抗微生物药物，那些击败了新冠病毒的幸运儿可能会死于另外一些早已为人所知的病原体。
不幸的是，新抗微生物药物的供应正日益枯竭。在青霉素面世不到100年之后，那些超级耐药细菌正逐渐在人类与细菌感染的斗争中占据上风。
众多超级细菌已经给世界各地的医疗保健系统造成了巨大损失。每年全球约有70万人死于耐药性。如果没有更好的新治疗方法，这一数字可能会在2050年增加到1000万。
We hope you're enjoying Project Syndicate.
To continue reading, subscribe now.
Subscribe
orRegister for FREE to access two premium articles per month.
Register
Already have an account? Log in